209 related articles for article (PubMed ID: 29020160)
1. Immune Cross-Opsonization Within emm Clusters Following Group A Streptococcus Skin Infection: Broadening the Scope of Type-Specific Immunity.
Frost HR; Laho D; Sanderson-Smith ML; Licciardi P; Donath S; Curtis N; Kado J; Dale JB; Steer AC; Smeesters PR
Clin Infect Dis; 2017 Oct; 65(9):1523-1531. PubMed ID: 29020160
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal Analysis of Group A Streptococcus emm Types and emm Clusters in a High-Prevalence Setting: Relationship between Past and Future Infections.
Campbell PT; Tong SYC; Geard N; Davies MR; Worthing KA; Lacey JA; Smeesters PR; Batzloff MR; Kado J; Jenney AWJ; Mcvernon J; Steer AC
J Infect Dis; 2020 Apr; 221(9):1429-1437. PubMed ID: 31748786
[TBL] [Abstract][Full Text] [Related]
3. Structure-based design of broadly protective group a streptococcal M protein-based vaccines.
Dale JB; Smeesters PR; Courtney HS; Penfound TA; Hohn CM; Smith JC; Baudry JY
Vaccine; 2017 Jan; 35(1):19-26. PubMed ID: 27890396
[TBL] [Abstract][Full Text] [Related]
4. Immune response against M protein-conserved region peptides from prevalent group A Streptococcus in a North Indian population.
Gupta VK; Sekhar S; Dhanda V; Toor D; Kumar R; Chakraborti A
J Microbiol Immunol Infect; 2016 Jun; 49(3):352-8. PubMed ID: 25087198
[TBL] [Abstract][Full Text] [Related]
5. Systematic Review and Meta-analysis of the Prevalence of Group A Streptococcal
Salie T; Engel K; Moloi A; Muhamed B; Dale JB; Engel ME
mSphere; 2020 Jul; 5(4):. PubMed ID: 32669471
[TBL] [Abstract][Full Text] [Related]
6. Concerns for efficacy of a 30-valent M-protein-based Streptococcus pyogenes vaccine in regions with high rates of rheumatic heart disease.
Giffard PM; Tong SYC; Holt DC; Ralph AP; Currie BJ
PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007511. PubMed ID: 31269021
[TBL] [Abstract][Full Text] [Related]
7. Comparative M-protein analysis of Streptococcus pyogenes from pharyngitis and skin infections in New Zealand: Implications for vaccine development.
Williamson DA; Smeesters PR; Steer AC; Morgan J; Davies M; Carter P; Upton A; Tong SY; Fraser J; Moreland NJ
BMC Infect Dis; 2016 Oct; 16(1):561. PubMed ID: 27733129
[TBL] [Abstract][Full Text] [Related]
8. Protective immunogenicity of group A streptococcal M-related proteins.
Dale JB; Niedermeyer SE; Agbaosi T; Hysmith ND; Penfound TA; Hohn CM; Pullen M; Bright MI; Murrell DS; Shenep LE; Courtney HS
Clin Vaccine Immunol; 2015 Mar; 22(3):344-50. PubMed ID: 25630406
[TBL] [Abstract][Full Text] [Related]
9. Bactericidal activity of M protein conserved region antibodies against group A streptococcal isolates from the Northern Thai population.
Yoonim N; Olive C; Pruksachatkunakorn C; Pruksakorn S
BMC Microbiol; 2006 Aug; 6():71. PubMed ID: 16895610
[TBL] [Abstract][Full Text] [Related]
10. Investigation of group A Streptococcus immune responses in an endemic setting, with a particular focus on J8.
Campbell PT; Frost H; Smeesters PR; Kado J; Good MF; Batzloff M; Geard N; McVernon J; Steer A
Vaccine; 2018 Nov; 36(50):7618-7624. PubMed ID: 30401621
[TBL] [Abstract][Full Text] [Related]
11. The emm-cluster typing system for Group A Streptococcus identifies epidemiologic similarities across the Pacific region.
Baroux N; D'Ortenzio E; Amédéo N; Baker C; Ali Alsuwayyid B; Dupont-Rouzeyrol M; O'Connor O; Steer A; Smeesters PR
Clin Infect Dis; 2014 Oct; 59(7):e84-92. PubMed ID: 24965347
[TBL] [Abstract][Full Text] [Related]
12. Group A streptococcal meningitis: emm type distribution and theoretical vaccine coverage in children.
Tuerlinckx D; Gueulette E; Loens K; Goossens H; Smeesters PR
Acta Clin Belg; 2016 Jun; 71(3):138-41. PubMed ID: 26319426
[TBL] [Abstract][Full Text] [Related]
13. [Distribution of emm genotypes and antibiotic susceptibility of Streptococcus pyogenes strains: analogy with the vaccine in development].
Arslan U; Oryaşın E; Eskin Z; Türk Dağı H; Fındık D; Tuncer I; Bozdoğan B
Mikrobiyol Bul; 2013 Apr; 47(2):318-23. PubMed ID: 23621731
[TBL] [Abstract][Full Text] [Related]
14. Potential coverage of a multivalent M protein-based group A streptococcal vaccine.
Dale JB; Penfound TA; Tamboura B; Sow SO; Nataro JP; Tapia M; Kotloff KL
Vaccine; 2013 Mar; 31(12):1576-81. PubMed ID: 23375817
[TBL] [Abstract][Full Text] [Related]
15. Protective immunity induced by an intranasal multivalent vaccine comprising 10 Lactococcus lactis strains expressing highly prevalent M-protein antigens derived from Group A Streptococcus.
Wozniak A; Scioscia N; García PC; Dale JB; Paillavil BA; Legarraga P; Salazar-Echegarai FJ; Bueno SM; Kalergis AM
Microbiol Immunol; 2018 Jun; 62(6):395-404. PubMed ID: 29704396
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology Analysis of Streptococcus pyogenes in a Hospital in Southern Taiwan by Use of the Updated emm Cluster Typing System.
Chiang-Ni C; Zheng PX; Wang SY; Tsai PJ; Chuang WJ; Lin YS; Liu CC; Wu JJ
J Clin Microbiol; 2016 Jan; 54(1):157-62. PubMed ID: 26560544
[TBL] [Abstract][Full Text] [Related]
17. Microbially synthesized modular virus-like particles and capsomeres displaying group A streptococcus hypervariable antigenic determinants.
Chuan YP; Wibowo N; Connors NK; Wu Y; Hughes FK; Batzloff MR; Lua LH; Middelberg AP
Biotechnol Bioeng; 2014 Jun; 111(6):1062-70. PubMed ID: 24338691
[TBL] [Abstract][Full Text] [Related]
18. Prospective Longitudinal Analysis of Immune Responses in Pediatric Subjects After Pharyngeal Acquisition of Group A Streptococci.
Hysmith ND; Kaplan EL; Cleary PP; Johnson DR; Penfound TA; Dale JB
J Pediatric Infect Dis Soc; 2017 Jun; 6(2):187-196. PubMed ID: 28204534
[TBL] [Abstract][Full Text] [Related]
19. The innate immune response elicited by Group A Streptococcus is highly variable among clinical isolates and correlates with the emm type.
Dinis M; Plainvert C; Kovarik P; Longo M; Fouet A; Poyart C
PLoS One; 2014; 9(7):e101464. PubMed ID: 24991887
[TBL] [Abstract][Full Text] [Related]
20. Combinatorial Synthetic Peptide Vaccine Strategy Protects against Hypervirulent CovR/S Mutant Streptococci.
Pandey M; Mortensen R; Calcutt A; Powell J; Batzloff MR; Dietrich J; Good MF
J Immunol; 2016 Apr; 196(8):3364-74. PubMed ID: 26969753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
